APGE Smart Money
Apogee Therapeutics, Inc.
1W: +0.1%
1M: +0.7%
3M: +60.4%
YTD: +78.2%
1Y: +256.8%
3Y: +478.9%
$135.07
Last traded 2026-09-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026341
Institutions Holding
+87 vs prior
105.3%
Ownership
+37.81%
118
New
84
Increased
112
Reduced
46
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | McKenna Mark C. | director | D-Sale to Issuer | 20,000 | $— | $0 | Filing |
| 2026-09-03 | Kiselak Tomas | director | D-Sale to Issuer | 51,166 | $— | $0 | Filing |
| 2026-09-03 | JONES WILLIAM A JR | director | D-Sale to Issuer | 34,824 | $— | $0 | Filing |
| 2026-09-03 | Dambkowski Carl | officer: chief medical officer | D-Sale to Issuer | 167,123 | $— | $0 | Filing |
| 2026-09-03 | Fox Jennifer A. | director | D-Sale to Issuer | 34,824 | $— | $0 | Filing |
| 2026-09-03 | HENDERSON MICHAEL THOMAS | officer: chief executive officer | D-Sale to Issuer | 920,941 | $— | $0 | Filing |
| 2026-09-03 | Shah Nimish P | director | D-Sale to Issuer | 1,750,000 | $135.11 | $236.4M | Filing |
| 2026-09-03 | Harwin Peter Evan | director | D-Sale to Issuer | 51,166 | $— | $0 | Filing |
| 2026-09-03 | Fairmount Funds Management LLC | director | D-Sale to Issuer | 340,855 | $— | $0 | Filing |
| 2026-09-03 | Fairmount Healthcare Fund II L.P. | director | D-Sale to Issuer | 340,855 | $— | $0 | Filing |
| 2026-09-03 | Kiselak Tomas | director | D-Sale to Issuer | 340,855 | $— | $0 | Filing |
| 2026-09-03 | Harwin Peter Evan | director | D-Sale to Issuer | 340,855 | $— | $0 | Filing |
| 2026-09-03 | Fairmount Funds Management LLC | director | D-Sale to Issuer | 51,166 | $— | $0 | Filing |
| 2026-09-03 | Fairmount Healthcare Fund II L.P. | director | D-Sale to Issuer | 51,166 | $— | $0 | Filing |
| 2026-09-03 | Henderson Jane | officer: chief financial officer | D-Sale to Issuer | 158,371 | $— | $0 | Filing |
| 2026-09-02 | Dambkowski Carl | officer: chief medical officer | D-Sale to Issuer | 1,375 | $135.06 | $186K | Filing |
| 2026-08-05 | Dambkowski Carl | officer: chief medical officer | S-Sale | 5,500 | $134.17 | $738K | Filing |
| 2026-07-24 | Henderson Jane | officer: chief financial officer | G-Gift | 15,000 | $— | $0 | Filing |
| 2026-07-14 | Dambkowski Carl | officer: chief medical officer | G-Gift | 8,000 | $— | $0 | Filing |
| 2026-07-10 | HENDERSON MICHAEL THOMAS | officer: chief executive officer | G-Gift | 75,046 | $— | $0 | Filing |
| 2026-07-08 | HENDERSON MICHAEL THOMAS | officer: chief executive officer | S-Sale | 20,000 | $133.63 | $2.7M | Filing |
| 2026-07-01 | Dambkowski Carl | officer: chief medical officer | S-Sale | 5,500 | $132.74 | $730K | Filing |
| 2026-06-22 | HENDERSON MICHAEL THOMAS | officer: chief executive officer | S-Sale | 80,000 | $132.54 | $10.6M | Filing |
| 2026-06-22 | Dambkowski Carl | officer: chief medical officer | S-Sale | 26,400 | $132.60 | $3.5M | Filing |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | officer: chief executive officer | S-Sale | 2,305 | $86.27 | $199K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Venrock Adviser, LLC | 8,493,321 | $1.1B | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 5,507,032 | $731M | +1,421,381 | 2026-06-30 | Filing |
| HBK INVESTMENTS L P | 2,850,000 | $378M | +2,850,000 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,572,119 | $341M | +70,024 | 2026-06-30 | Filing |
| FMR LLC | 2,493,137 | $331M | -6,769,154 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,297,743 | $305M | +134,779 | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 1,740,101 | $231M | -180,699 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,693,341 | $225M | +1,040,751 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 1,665,102 | $221M | +1,226,448 | 2026-06-30 | Filing |
| GLAZER CAPITAL, LLC | 1,641,042 | $218M | +1,641,042 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 1,576,385 | $209M | +228,142 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,528,750 | $203M | +1,132,420 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 1,491,404 | $198M | +1,398,812 | 2026-06-30 | Filing |
| Pentwater Capital Management LP | 1,425,000 | $189M | +1,425,000 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,421,681 | $189M | +826,649 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,314,868 | $175M | +97,579 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 1,308,113 | $174M | -232,271 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 1,193,626 | $158M | +1,193,626 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 1,126,139 | $149M | +225,268 | 2026-06-30 | Filing |
| Affinity Asset Advisors, LLC | 987,000 | $131M | -297,926 | 2026-06-30 | Filing |